Search

everythinglearnresearchcommunity

for

Search:↓

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tazarotene gel may be more effective for acne than adapalene gel.

Bicalutamide shows promise for treating female hair loss.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The niosomes effectively target hair follicles for acne treatment.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Upadacitinib effectively treats psoriasis and lichen planus together.

Compound 4 is a promising treatment for hair loss with low toxicity.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.